Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The cell motility modulator Slit2 is a potent inhibitor of platelet function.

Patel S, Huang YW, Reheman A, Pluthero FG, Chaturvedi S, Mukovozov IM, Tole S, Liu GY, Li L, Durocher Y, Ni H, Kahr WH, Robinson LA.

Circulation. 2012 Sep 11;126(11):1385-95. doi: 10.1161/CIRCULATIONAHA.112.105452. Epub 2012 Aug 3.

2.

Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation.

Liu D, Hou J, Hu X, Wang X, Xiao Y, Mou Y, De Leon H.

Circ Res. 2006 Mar 3;98(4):480-9. Epub 2006 Jan 26.

3.

Potential anti-angiogenic role of Slit2 in corneal neovascularization.

Han X, Zhang MC.

Exp Eye Res. 2010 Jun;90(6):742-9. doi: 10.1016/j.exer.2010.03.007. Epub 2010 Mar 16.

PMID:
20298689
4.

The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils.

Tole S, Mukovozov IM, Huang YW, Magalhaes MA, Yan M, Crow MR, Liu GY, Sun CX, Durocher Y, Glogauer M, Robinson LA.

J Leukoc Biol. 2009 Dec;86(6):1403-15. doi: 10.1189/jlb.0609391. Epub 2009 Sep 16.

5.

Slit2-N inhibits PDGF-induced migration in rat airway smooth muscle cells: WASP and Arp2/3 involved.

Ning Y, Sun Q, Dong Y, Xu W, Zhang W, Huang H, Li Q.

Toxicology. 2011 Apr 28;283(1):32-40. doi: 10.1016/j.tox.2011.01.026. Epub 2011 Feb 17.

PMID:
21315131
6.

The Neurorepellent Slit2 Inhibits Postadhesion Stabilization of Monocytes Tethered to Vascular Endothelial Cells.

Mukovozov I, Huang YW, Zhang Q, Liu GY, Siu A, Sokolskyy Y, Patel S, Hyduk SJ, Kutryk MJ, Cybulsky MI, Robinson LA.

J Immunol. 2015 Oct 1;195(7):3334-44. doi: 10.4049/jimmunol.1500640. Epub 2015 Aug 21.

PMID:
26297762
7.

Slit2-Robo signaling: a novel regulator of vascular injury.

Yuen DA, Robinson LA.

Curr Opin Nephrol Hypertens. 2013 Jul;22(4):445-51. doi: 10.1097/MNH.0b013e32836235f4. Review.

PMID:
23736842
8.

The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells.

Schmid BC, Rezniczek GA, Fabjani G, Yoneda T, Leodolter S, Zeillinger R.

Breast Cancer Res Treat. 2007 Dec;106(3):333-42. Epub 2007 Feb 1.

PMID:
17268810
9.

Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner.

Barbieri SS, Amadio P, Gianellini S, Tarantino E, Zacchi E, Veglia F, Howe LR, Weksler BB, Mussoni L, Tremoli E.

Circulation. 2012 Sep 11;126(11):1373-84. doi: 10.1161/CIRCULATIONAHA.112.097295. Epub 2012 Aug 3.

10.

The axonal repellent Slit2 inhibits pericyte migration: potential implications in angiogenesis.

Guijarro-Muñoz I, Cuesta AM, Alvarez-Cienfuegos A, Geng JG, Alvarez-Vallina L, Sanz L.

Exp Cell Res. 2012 Feb 15;318(4):371-8. doi: 10.1016/j.yexcr.2011.12.005. Epub 2011 Dec 14.

PMID:
22198087
11.

Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.

Hoylaerts MF.

Verh K Acad Geneeskd Belg. 1997;59(3):161-83. Review.

PMID:
9490916
12.

Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress.

Edelstein LC, Luna EJ, Gibson IB, Bray M, Jin Y, Kondkar A, Nagalla S, Hadjout-Rabi N, Smith TC, Covarrubias D, Jones SN, Ahmad F, Stolla M, Kong X, Fang Z, Bergmeier W, Shaw C, Leal SM, Bray PF.

Circulation. 2012 Jun 5;125(22):2762-71. doi: 10.1161/CIRCULATIONAHA.112.091462. Epub 2012 May 1.

13.

Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.

Kawasaki T, Dewerchin M, Lijnen HR, Vermylen J, Hoylaerts MF.

Blood. 2000 Jul 1;96(1):153-60.

14.

Cooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis.

Dunaway CM, Hwang Y, Lindsley CW, Cook RS, Wu JY, Boothby M, Chen J, Brantley-Sieders DM.

Mol Cell Biol. 2011 Feb;31(3):404-16. doi: 10.1128/MCB.00667-10. Epub 2010 Dec 6.

15.

Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity.

Wang B, Xiao Y, Ding BB, Zhang N, Yuan Xb, Gui L, Qian KX, Duan S, Chen Z, Rao Y, Geng JG.

Cancer Cell. 2003 Jul;4(1):19-29.

16.

Vitronectin inhibits the thrombotic response to arterial injury in mice.

Fay WP, Parker AC, Ansari MN, Zheng X, Ginsburg D.

Blood. 1999 Mar 15;93(6):1825-30.

17.

Slit2-Robo signaling in inflammation and kidney injury.

Chaturvedi S, Robinson LA.

Pediatr Nephrol. 2015 Apr;30(4):561-6. doi: 10.1007/s00467-014-2825-4. Epub 2014 Apr 29. Review.

PMID:
24777535
18.

Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.

Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S, Kuziel WA, Weber C.

Circ Res. 2004 Nov 26;95(11):1125-33. Epub 2004 Nov 4.

19.

Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation.

Reheman A, Gross P, Yang H, Chen P, Allen D, Leytin V, Freedman J, Ni H.

J Thromb Haemost. 2005 May;3(5):875-83. Epub 2005 Feb 23.

PMID:
15733060
20.

Prothrombotic effects of diclofenac on arteriolar platelet activation and thrombosis in vivo.

Struthmann L, Hellwig N, Pircher J, Sohn HY, Buerkle MA, Klauss V, Mannell H, Pohl U, Krötz F.

J Thromb Haemost. 2009 Oct;7(10):1727-35. doi: 10.1111/j.1538-7836.2009.03582.x. Epub 2009 Aug 19.

PMID:
19691487
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk